Treatment features of cilliary arrhythmia in patients with ischemic heart disease in combination with diabetes innocens.

Abstract

We studied the efficacy of amiodarone in the 34 coronary heart disease patients suffering from paroxysmal or sustained atrial fibrillation. The functionality of the patients corresponded to II-III functional class NYHA. 18 patients had compensated diabetes II-type, mild to moderate severity. 19 patients (55.9%) had previous myocardial infarction within the period of 6 months of me-up to 2 years. Among them, 11 patients (32.4%) suffered from diabetes. Surveyed patients had exertional angina II-III functional class. The age of patients ranged from 43 to 59 years. Amiodarone has a pronounced antiarrhythmic effect in most patients with atrial fibrillation sufferers as coronary heart disease and ischemic heart disease and diabetes II-type. Treatment with amiodarone has no negative effect on cardiohemodynamics patients examined. Additional useful property of the drug - antianginal effect. Prophylactic administration of amiodarone for the prevention of recurrence of atrial fibrillation is less effective in patients with concomitant diabetes mellitus II-type.